Filed: 8/17/2026ACC: 0001013594-26-000921
📋 What this filing means
SEVEN FLEET CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 96 equity positions with a total reported market value of $605.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
96
Positions
$605.92M
Total AUM (reported)
29.22M
Total Shares
Allocation by class
COM$449.66M74.2%
COM NEW$82.65M13.6%
COM SHS$20.87M3.4%
SPONSORED ADS$17.58M2.9%
SHS$9.89M1.6%
COMMON STOCK$9.84M1.6%
ORD SHS$3.17M0.5%
Portfolio Concentration
Top 3$275.01M45.4%
4–10$119.69M19.8%
11–25$117.27M19.4%
Rest$93.95M15.5%
Top 3 weight
45.4%
Top 10 weight
65.1%
Voting Authority Distribution
Total shares with voting rights: 29.22M
Sole
Full voting authority
20.75M
shares
% of voting shares71.0%
Shared
Joint voting authority
8.46M
shares
% of voting shares29.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole93
Shared0
Other3
Dominant voting typeSole · 71.0% of voting shares
Institutional Holdings96
Rows:
CG ONCOLOGY INC
SOLEShares1.89M
TypeSH
Market value$134.02M
22.12%
Sole
446.84K
Shared
1.44M
None
0.00
TANGO THERAPEUTICS INC
SOLEShares3.23M
TypeSH
Market value$95.66M
15.79%
Sole
1.91M
Shared
1.32M
None
0.00
REVOLUTION MEDICINES INC
SOLEShares242.03K
TypeSH
Market value$45.33M
7.48%
Sole
194.36K
Shared
47.67K
None
0.00
PHARVARIS N V
SOLEShares774.50K
TypeSH
Market value$26.78M
4.42%
Sole
291.98K
Shared
482.52K
None
0.00
LIQUIDIA CORPORATION
SOLEShares256.60K
TypeSH
Market value$20.46M
3.38%
Sole
182.10K
Shared
74.50K
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares365.39K
TypeSH
Market value$18.54M
3.06%
Sole
289.14K
Shared
76.25K
None
0.00
ABIVAX SA
SOLEShares111.33K
TypeSH
Market value$14.84M
2.45%
Sole
111.33K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares770.76K
TypeSH
Market value$14.24M
2.35%
Sole
438.55K
Shared
332.21K
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares110.39K
TypeSH
Market value$12.92M
2.13%
Sole
110.39K
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares433.15K
TypeSH
Market value$11.90M
1.96%
Sole
206.73K
Shared
226.41K
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares4.35M
TypeSH
Market value$10.65M
1.76%
Sole
2.95M
Shared
1.40M
None
0.00
CYTOKINETICS INC
SOLEShares118.24K
TypeSH
Market value$10.07M
1.66%
Sole
118.24K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares1.50M
TypeSH
Market value$9.94M
1.64%
Sole
1.50M
Shared
0.00
None
0.00
VERADERMICS INC
SOLEShares80K
TypeSH
Market value$9.84M
1.62%
Sole
10K
Shared
70K
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares246.61K
TypeSH
Market value$8.57M
1.41%
Sole
246.61K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares117.07K
TypeSH
Market value$7.91M
1.31%
Sole
117.07K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares368.31K
TypeSH
Market value$7.83M
1.29%
Sole
368.31K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares220.13K
TypeSH
Market value$7.79M
1.29%
Sole
220.13K
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares284.43K
TypeSH
Market value$7.40M
1.22%
Sole
154.43K
Shared
130K
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares28.83K
TypeSH
Market value$7.06M
1.16%
Sole
28.83K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares148.65K
TypeSH
Market value$6.99M
1.15%
Sole
148.65K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares64.72K
TypeSH
Market value$6.31M
1.04%
Sole
43.67K
Shared
21.05K
None
0.00
COGENT BIOSCIENCES INC
SOLEShares147.51K
TypeSH
Market value$5.71M
0.94%
Sole
147.51K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares308.01K
TypeSH
Market value$5.64M
0.93%
Sole
210.35K
Shared
97.66K
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares45.40K
TypeSH
Market value$5.57M
0.92%
Sole
45.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 1.89M | SH | $134.02M 22.12% | 446.84K | 1.44M | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 3.23M | SH | $95.66M 15.79% | 1.91M | 1.32M | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 242.03K | SH | $45.33M 7.48% | 194.36K | 47.67K | 0.00 |
PHARVARIS N VSOLE | COM | 774.50K | SH | $26.78M 4.42% | 291.98K | 482.52K | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 256.60K | SH | $20.46M 3.38% | 182.10K | 74.50K | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 365.39K | SH | $18.54M 3.06% | 289.14K | 76.25K | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 111.33K | SH | $14.84M 2.45% | 111.33K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 770.76K | SH | $14.24M 2.35% | 438.55K | 332.21K | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 110.39K | SH | $12.92M 2.13% | 110.39K | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 433.15K | SH | $11.90M 1.96% | 206.73K | 226.41K | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 4.35M | SH | $10.65M 1.76% | 2.95M | 1.40M | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 118.24K | SH | $10.07M 1.66% | 118.24K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 1.50M | SH | $9.94M 1.64% | 1.50M | 0.00 | 0.00 |
VERADERMICS INCSOLE | COMMON STOCK | 80K | SH | $9.84M 1.62% | 10K | 70K | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 246.61K | SH | $8.57M 1.41% | 246.61K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 117.07K | SH | $7.91M 1.31% | 117.07K | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 368.31K | SH | $7.83M 1.29% | 368.31K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 220.13K | SH | $7.79M 1.29% | 220.13K | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | COM NEW | 284.43K | SH | $7.40M 1.22% | 154.43K | 130K | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 28.83K | SH | $7.06M 1.16% | 28.83K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 148.65K | SH | $6.99M 1.15% | 148.65K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 64.72K | SH | $6.31M 1.04% | 43.67K | 21.05K | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 147.51K | SH | $5.71M 0.94% | 147.51K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 308.01K | SH | $5.64M 0.93% | 210.35K | 97.66K | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 45.40K | SH | $5.57M 0.92% | 45.40K | 0.00 | 0.00 |
Page 1 of 4